ASX-Dividend-Report-Banner

AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023

October 31, 2023 02:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023
Image source: Kalkine Media
  • Recently achieved MDSAP certification and ISO/IEC 27001, 27017, 27018 certifications, paving the way for accelerated expansion into global markets.
  • Certified Japan's Pharmaceuticals and Medical Devices Agency (PMDA), signaling the beginning of its full-scale expansion into the Japanese market.
  • Attending at RSNA 2023 as an AI showcase sponsor, showcasing clinical achievements with two AI Theater Presentations and two accepted abstracts.

SEOUL, South Korea, Oct. 30, 2023 /PRNewswire/ -- AIRS Medical has shown remarkable growth in global market expansion. The company received MDSAP (Medical Device Single Audit Program) certification, followed by achieving three ISO certifications related to information security in September. Also, AIRS Medical gained approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) on October 13th. These achievements have accelerated global expansion, including the Japanese market. AIRS Medical will showcase SwiftMR™, an AI-powered MRI enhancement solution at RSNA2023, the largest radiological conference in North America on November 24~29th.

SwiftMR™ is an AI-powered MRI reconstruction solution that enhances the quality of MRI images through fine-tuned deep learning technology. It is capable of reducing MRI scan times by up to 50% while enhancing the image quality. Since its official launch in 2021, SwiftMR™ has been installed in over 250 institutions in global markets, including the United States. Recently, it has accumulated over 900,000+ processed exams in less than a year compared to last year - where only 300,000+ exams were processed up until Nov 2022. This remarkable threefold increase shows how SwiftMR™ is effective all over the world.

AIRS Medical attributes its exceptional growth to a result of aggressive global expansion. By targeting the global market from the beginning of product development, the company was able to clear US FDA 510(k) within only three months of launch. Subsequently, the company achieved approvals in various countries including Asia-Pacific, Brazil, and the UAE. AIRS Medical achieved MDSAP(Medical Device Single Audit Program encompassing five different countries including Japan.) certification in August and also achieved another milestone by becoming the first company in the medical AI industry to receive all three international standard information security certifications (ISO/IEC 27001, 27017, 27018). AIRS Medical accelerates international expansion with the recent certification of Japan's Pharmaceuticals and Medical Devices Agency (PMDA) on October 13th.

"Japan holds strategic importance as a target market, due to its expansive market size and the diversity of MRI scanners. We have strong confidence in SwiftMR's potential for success in the Japanese market, driven by its vendor-neutral attributes and the convenience of installation." said Hyeseong Lee, CEO of AIRS Medical. "Following Japan market, we will accelerate global expansion with the aim of entering the European market by the end of the year."

AIRS Medical will be attending RSNA2023 as an AI Showcase sponsor, the largest radiology conference in North America which will be held on November 24. At RSNA 2023, the company will present two AI Theater Presentations and two research abstracts, showcasing domestic and international clinical research outcomes and success cases of SwiftMR™. To get a sneak peek of RSNA 2023.

Kevin Yang, Head of AIRS Medical's U.S. branch and Clinical Research team said, "We are delighted to present clinical research collaboration outcomes and success stories of SwiftMR™ which supports our technological excellence at the RSNA. Our team's grand aim is to make SwiftMR™ a universal standard in all MRI scanners."

About AIRS Medical Inc.

AIRS Medical is a leading healthcare AI company that envisions patient-friendly healthcare by transforming the inefficiencies in the medical industry through innovative technology, enabling more people to access healthcare when needed. The company was awarded "2023 North American Technology Innovation Leadership Award" by Frost & Sullivan in 2023 and named one of "96 AI Companies building the next generation of radiology tech" by CB Insights. AIRS Medical offers SwiftMR, an AI-Powered MRI Reconstruction solution. They are also working on an AI-Powered Venipuncture automation solution to be released soon. Visit airsmed.com to learn more.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.